We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current REVB market cap is 2.19M. The company's latest EPS is USD -0.2298 and P/E is -0.09.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.78M | -2.33M | -1.9M | -2.52M | -1.8M |
| Net Income | -2.63M | -2.2M | -2.68M | -8.39M | -2.24M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4k | -145k | -3.09M | -10.87M | -8.66M |
| Net Income | -4k | -136k | -2.13M | -10.83M | -120k |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.22M | 12.21M | 14.7M | 12.27M | 6.74M |
| Total Liabilities | 5.4M | 5.57M | 5.23M | 11.13M | 4.07M |
| Total Equity | 8.82M | 6.65M | 9.47M | 1.14M | 2.67M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 23k | 74.16M | 48.39M | 5.5M | 12.21M |
| Total Liabilities | 27k | 2.95M | 8.4M | 4.45M | 5.57M |
| Total Equity | -4k | 5M | -7.82M | 1.05M | 6.65M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.28M | -7.29M | -2.84M | -5.32M | -14.57M |
| Investing | N/A | N/A | -19k | -19k | -37k |
| Financing | 14.03M | 14.03M | 5.42M | 5.42M | 9.16M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | -219k | -726k | -11.22M | -7.29M |
| Investing | N/A | -74.04M | 25.74M | N/A | N/A |
| Financing | N/A | 74.27M | -24.95M | 15.2M | 14.03M |
| Market Cap | 2.19M |
| Price to Earnings Ratio | -0.09 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 522.28k |
| Average Volume (1 week) | 430.13k |
| Average Volume (1 Month) | 682.23k |
| 52 Week Change | 35.21% |
| 52 Week High | 4.70 |
| 52 Week Low | 0.2258 |
| Spread (Intraday) | 0.06 (1.43%) |
| Company Name | Revelation Biosciences Inc |
| Address |
16192 coastal hwy lewes, delaware 19958 |
| Website | https:// |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
